logo-loader
viewVenus Metals Corporation Ltd

Venus Metals shares rise after agreeing to sell Nardoo Hill tenement to eMetals Limited

The company’s shares were last trading 7.41% higher intra-day while the S&P/ASX 200 crashed 9.7%.

Venus Metals Corporation Ltd - Venus Metals shares rise after agreeing to sell Nardoo Hill tenement to eMetals Limited
Venus will retain exposure to the tenement through royalty

Venus Metals Corporation Limited (ASX:VMC) has entered into a binding term sheet with eMetals Limited (ASX:EMT) to sell its Nardoo Hill mineral tenement E09/2156.

eMetals recently relisted on ASX after raising about $4.3 million and owns the tenement abutting E09/2156.  

Consideration for the sale of the tenement and other related mining information is:

  • $15,000 in immediately available funds;
  • 25,000,000 fully paid ordinary shares in the capital of eMetals at deemed issue price of 1.4 cents per share; and
  • a royalty of 50 cents per tonne of ore extracted from the area within the tenement payable in cash.

The consideration, through the royalty and issue of shares in eMetals, allows Venus to retain exposure to the tenement. 

Exploring for Penny-West style gold

Venus and joint venture partner Rox Resources Limited (ASX:RXL) recently identified strong conductive electromagnetic anomalies from an Xcite heli‐borne electromagnetic survey (HEM) at the Penny West Deep South Project.

The JV partners are exploring for Penny-West style gold mineralisation along the prospective Youanmi Shear Zone in Western Australia.

The conductive zones detected extend over two to three flight lines providing a strike length of 200-400 metres, which is similar in size to the nearby Penny West open cut mine.

Quick facts: Venus Metals Corporation Ltd

Price: 0.17 AUD

ASX:VMC
Market: ASX
Market Cap: $25.68 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Venus Metals Corporation Ltd named herein, including the promotion by the Company of Venus Metals Corporation Ltd in any Content on the Site,...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Kazia Therapeutics working on moving its flagship Paxalisib drug into...

  Kazia Therapeutics Ltd's (ASX:KZA) James Garner speaks to Proactive's Andrew Scott after releasing a poster presentation of interim data from the ongoing phase II study of Paxalisib in glioblastoma at the prestigious American Society of Clinical Oncology (ASCO) annual meeting. Analysis...

1 hour, 57 minutes ago

2 min read